1 min read

ASH Annual Meeting  | Supporting Blood Cancer Clinical Trials

Email Header Image_ASH 2_SEarch Image.png

Veristat is excited to head to Atlanta, GA for the 59th ASH Annual Meeting & Exposition taking place from December 9-12, 2017.   The 2017 ASH Annual Meeting is the place to  network with a global community of more than 25,000 hematology professionals who specialize in performing clinical research and treating patients with both malignant and non-malignant hematology diseases. 

 

Visit Our Booth #3247

While this is not our first year attending ASH, it’s our first year with an exhibit booth! 

Simply stop by our booth #3247 to say hello or fill out the form on the right side of this page to schedule a time to meet with Veristat at ASH to discuss your current challenges. 

By visiting with Veristat at ASH, you will meet some of our senior leaders and  experts who have guided our clients through the clinical trial and regulatory submission process.   In the past five years, we have worked on nearly 50  blood disease/blood cancer clinical programs.  And, we are currently preparing  3 regulatory submissions for leukemia, and 2 genetic blood disorders.

 

Learn more

Veristat can help you navigate the challenges in the clinical trial and regulatory submission process for your next hematology study or programs.    Read about our hematologic malignancy experience now.

Share This Event:

   

1 min read

Chief Medical Officer Summit -CMO 360°

Meet the Veristat team at Booth #3, April 17th and 18th in Boston

The Science-First CRO™ and Consultancy Ready to...

4 min read

Plenary Session Presentation: Putting Science First in Rare Disease Studies

Don´t miss Veristat’s plenary presentation at the World Orphan Drug Congress (WODC), Boston, Thursday, April 25th at...